| 注册
首页|期刊导航|中国药业|沙美特罗联合布地奈德治疗哮喘37例

沙美特罗联合布地奈德治疗哮喘37例

南建军 周颖

中国药业2011,Vol.20Issue(19):73-75,3.
中国药业2011,Vol.20Issue(19):73-75,3.

沙美特罗联合布地奈德治疗哮喘37例

Effect of Salmeterol Combined Budesonide in Treating 37 Cases of Asthma

南建军 1周颖2

作者信息

  • 1. 浙江省乐清市第三人民医院药剂科,浙江,温州,325604
  • 2. 温州医学院附属第一医院呼吸内科,浙江,温州,325000
  • 折叠

摘要

Abstract

Objective To investigate the effect of combination of salmeterol and budesonide in the treatment of asthma. Methods Seventy-four cases of asthma were randomly divided into the treatment group and the control group, 37 cases in each group. The treatment group received the conventional therapy plus budesonide combined salmeterol (Seretide) dry powder, 50 μg/250 μg inhalation, twice a day. The control group was treated by conventional therapy plus budesonide aerosol inhalation, 200 μg per time, twice daily. The treatment course in both two groups was 15 d. The effects were evaluated by the asthma symptom scores, lung function and the ACT scoring after 3-month treatment. Results The asthma symptom score, lung funcetion and ACT score in the two groups all were improved. But the improvement in the treatment group was more significant than that in the control group with statistical significance( P <0. 01). Conclusion The combination therapy of salmeterol and budesonide has better control effects on asthma with good efficacy, convenience and economy, which is consistent with the clinical application and dissemination.

关键词

沙美特罗/布地奈德/哮喘

Key words

salmeterol/ budesonide/ asthma

分类

医药卫生

引用本文复制引用

南建军,周颖..沙美特罗联合布地奈德治疗哮喘37例[J].中国药业,2011,20(19):73-75,3.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文